rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2000-11-28
|
pubmed:abstractText |
On the base of clinical psychological and electrophysiological studies of 34 patients with primary manifestations of brain circulation insufficiency good tolerance and high efficiency of Tanakan course treatment (3 x 40 mg/day for 3 months) were showen. Tanakan decreased manifestations of clinical syndrome, improved psychological functions and electrophysiological parameters. Prospective study supported the stability of positive changes in the status of patients for 12 months after Tanakan course treatment.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1997-7298
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
100
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
29-34
|
pubmed:dateRevised |
2008-3-31
|
pubmed:meshHeading |
pubmed-meshheading:10983364-Aged,
pubmed-meshheading:10983364-Aged, 80 and over,
pubmed-meshheading:10983364-Cognition,
pubmed-meshheading:10983364-Dementia,
pubmed-meshheading:10983364-Dose-Response Relationship, Drug,
pubmed-meshheading:10983364-Female,
pubmed-meshheading:10983364-Humans,
pubmed-meshheading:10983364-Male,
pubmed-meshheading:10983364-Middle Aged,
pubmed-meshheading:10983364-Psychotic Disorders,
pubmed-meshheading:10983364-Psychotropic Drugs,
pubmed-meshheading:10983364-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
[The use of clopixole in therapy of aged mental patients].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|